Expanding Orthopedics announced that its FLXfit, a 3D expandable interbody cage, has received the CE Mark and is cleared for commercialization in Europe.
The cage is intended for use in the minimally invasive treatment for lumbar degenerative disc disease. "FLXfit's innovative design is based on EOI's expanding devices' IP portfolio enabling an 'all-in-one' solution for interbody fusion. The FLXfit combines minimal invasive access, maximum footprint support, large bone graft chamber with unique lordotic expansion for optimal anatomical fit," said Ofer Bokobza, CEO of Expanding Orthopedics in a news release.
More Articles on Devices:
5 Key Results: LDR's Mobi-C Artificial Disc Replacement vs. ACDF
FDA Clears AccelSPINE's Next Generation Minimally Invasive Spine System
Global Medical Device Market to Grow at 6.2% Annually Until 2018